pharmacopeia

Magnesium Sulfate Heptahydrate

US-FDASourced from openFDA
GET
/api/v1/drug/magnesium-sulfate-heptahydrate

Indications

Sourced from openFDA
  • Uses For relief of occasional constipation (irregularity). This product generally produces bowel movement in ½ to 6 hours.ICD-10: K59.00

Dosage & administration

Sourced from openFDA

Directions tbsp = tablespoon drink a full glass (8 ounces) of liquid with each dose. The dose may be taken as a single daily dose or in divided doses. do not exceed maximum daily dosage, unless directed by a doctor adults and children 12 years of age and over 10 (3/4 tbsp.) to 30 grams (2 ½ tbsps.) children 6 to under 12 years of age 5 (½ tbsp.) to 10 grams (3/4 tbsp.) children under 6 years of age consult a doctor

Warnings & precautions

Sourced from openFDA

Do not use laxative products for more than 1 week unless directed Ask a doctor before use if you have abdominal pain, nausea, or vomiting are present noticed a sudden change in bowel habits that persists over a period of 2 weeks kidney disease a magnesium-restricted diet Stop use and ask a doctor if rectal bleeding occurs you fail to have a bowel movement after use of a laxative. This may indicate a serious condition. If pregnant or breast-feeding ask a health professional before use. Keep this and all drugs out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Approval history

Sourced from openFDA
  • Sep 8, 1986NDANDA019316Fresenius Kabi Usa
  • Mar 7, 2016ANDAANDA206486Fresenius Kabi Usa
  • Mar 15, 2016ANDAANDA206485Fresenius Kabi Usa
  • Jun 1, 2020ANDAANDA211966Baxter Hlthcare Corp
  • Jul 10, 2020ANDAANDA213917Gland
  • Oct 27, 2020ANDAANDA207966B Braun Medical
  • Apr 26, 2021ANDAANDA207967B Braun Medical
  • May 28, 2025ANDAANDA219777Aspiro

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
13,235 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Drug Ineffective1,2109.1%
  2. 2Nausea8536.4%
  3. 3Off Label Use8376.3%
  4. 4Pyrexia7886.0%
  5. 5Maternal Exposure During Pregnancy7555.7%
  6. 6Pain7315.5%
  7. 7Foetal Exposure During Pregnancy6795.1%
  8. 8Diarrhoea6655.0%
  9. 9Premature Baby6615.0%
  10. 10Dyspnoea6044.6%
  11. 11Hypotension5534.2%
  12. 12Anaemia5524.2%
  13. 13Vomiting5244.0%
  14. 14Pneumonia4963.7%
  15. 15Fatigue4853.7%

Literature

View JSON

Recent PubMed references pinned to Magnesium Sulfate Heptahydrate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 528 ClinicalTrials.gov registrations naming Magnesium Sulfate Heptahydrate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

What is Magnesium Sulfate Heptahydrate used for?
According to FDA labeling, Magnesium Sulfate Heptahydrate carries indications including: Uses For relief of occasional constipation (irregularity). This product generally produces bowel movement in ½ to 6 hours.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for magnesium-sulfate-heptahydrate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients